Delivery Order SPE2DB22D2206-SPE2DB25FHX30

Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $54K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,584.15 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, and has a completion date of July 14, 2025. This order is not a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,728.88 contract is for the supply of the medication FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has an ultimate completion date of July 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
This is a firm fixed-price delivery order for $15,352.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has an ultimate completion date of May 23, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,601.43 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, to supply 4568723526 FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has an ultimate completion date of July 8, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor...
The U.S. Defense Logistics Agency (DLA) awarded a $1,833.32 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the supply of 4567733697 - FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The contract has an ultimate completion date of March 31, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,384.01, is a Firm Fixed Price Delivery Order contract for the procurement of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a pharmaceutical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,176.29, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,440.46 firm fixed-price delivery order is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,772.06 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication, with a ceiling value of $48,179.94. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on July 9, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHX30
    Delivery Order

This is a $54,143.25 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) through May 2026.

Generated 10/14/25, 10:51 AM